These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6087581)

  • 1. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A].
    Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of anti-hepatitis immunoglobulins on the intensity of the immunity to the hepatitis A virus].
    Perepelkin VS; Katkov AI; Semenenko TA; Mikhaĭlov MI; Vasil'eva VI
    Voen Med Zh; 1993 Feb; (2):37-8. PubMed ID: 8388594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic effectiveness of immunoglobulin preparations with different amounts of specific antibodies to the hepatitis A virus].
    Perepelkin VS; Sumarokov AA; Gorbunov MA; Tiantov GA; Borzykh VA
    Voen Med Zh; 1988 Dec; (12):37-9. PubMed ID: 2853893
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viral hepatitis A: specific immunological aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):167-9. PubMed ID: 6099083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis.
    Iwarson S; Frösner G; Norkrans G
    Infection; 1978; 6(6):257-8. PubMed ID: 215556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific anti-HAV immunoglobulin.
    Goudemand M; Maniez-Montreuil M; Dupressoir-Burlet MV
    Lancet; 1993 Jul; 342(8865):239. PubMed ID: 8100956
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin.
    Gerety RJ; Smallwood LA; Finlayson JS; Tabor E
    Dev Biol Stand; 1983; 54():411-6. PubMed ID: 6317492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylaxis of hepatitis A of the children by immune serum globulin.
    Kinoshita R; Hirose S; Miura K; Nakagawa T; Imai Y; Suzuki S
    Gastroenterol Jpn; 1984 Jun; 19(3):211-5. PubMed ID: 6086439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hepatitis A antibody before prescribing standard immunoglobulin for Europeans staying in tropical areas.
    Larouze B; Gaudebout C; Foulon G; Mercier E; Ancelle JP
    Lancet; 1984 Feb; 1(8374):449-50. PubMed ID: 6142171
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis A in Peru. The role of children.
    Kilpatrick ME; Escamilla J
    Am J Epidemiol; 1986 Jul; 124(1):111-3. PubMed ID: 3013000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization against hepatitis A.
    Stapleton JT
    Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.
    Kendall BJ; Cooksley WG
    Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A trial to decrease hepatitis A morbidity in Dzerzhinsk, Gorki Province].
    Aleĭnik MD; Fedotov VA; Bystrova TN; Smirnova ON; Aksenova LM
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Mar; (3):52-6. PubMed ID: 2164290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM].
    Barin F; Lesage G; Dubois F; Yvonnet B; Coursaget P; Goudeau A
    Pathol Biol (Paris); 1983 Dec; 31(10):825-8. PubMed ID: 6322094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A-virus in cell culture. V. Neutralizing antibodies against hepatitis A-virus.
    Zahn J; Vallbracht A; Flehmig B
    Med Microbiol Immunol; 1984; 173(1):9-17. PubMed ID: 6088963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and persistence of specific IgA antibodies in serum of patients with hepatitis A by capture radioimmunoassay.
    Sikuler E; Keynan A; Hanuka N; Friedman MG; Sarov I
    J Med Virol; 1983; 11(4):287-94. PubMed ID: 6308139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of human and rabbit antisera to hepatitis A virus.
    Gauss-Müller V; Deinhardt F
    J Med Virol; 1988 Feb; 24(2):219-28. PubMed ID: 2832540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum antibodies to the hepatitis A virus in persons following a history of the infection].
    Prikazchikov SA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):72-5. PubMed ID: 3033953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis A of children. Seroepidemiological study among French urban population (author's transl)].
    Drucker J; Coursaget P; Maupas P; Nivet H; Grenier B; Gerety R
    Nouv Presse Med; 1979 May; 8(21):1735-8. PubMed ID: 221882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.